Family Medicine · Sugarloaf, PA
NPI
1942275854
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
102 Banks Ave
Sugarloaf, PA, 18249
Phone (570) 788-5104
Groups this clinician bills Medicare through
Medicare paid, 2024
$144K
4,912 services
Medicare patients, 2024
538
Average age 73
Drug cost, 2024
$1.3M
17,626 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Eugene D Gorski was code J1010 (injection, methylprednisolone acetate, 1 mg), 2,081 times for 24 patients. In total Eugene D Gorski billed 4,912 services in 44 codes, and Medicare paid $144K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-02-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 2,081 | 24 | $0.09 | $192 |
| 99213 Office E&M - Established | Office | 783 | 435 | $54.52 | $43K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 385 | 385 | $122.36 | $47K |
| 83036 Blood Count | Office | 194 | 117 | $9.47 | $1,837 |
| 96372 Injection Administration | Office | 164 | 61 | $8.45 | $1,386 |
| G0008 Administration of influenza virus vaccine | Office | 139 | 135 | $30.77 | $4,277 |
| 90662 Vaccine Product | Office | 130 | 126 | $80.58 | $10K |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 112 | 30 | $0.76 | $85.3 |
| 99214 Office E&M - Established | Office | 72 | 65 | $77.55 | $5,583 |
| 90480 Vaccine Administration | Office | 57 | 57 | $40.31 | $2,298 |
| 91320 Vaccine Product | Office | 57 | 57 | $149.67 | $8,531 |
| 81002 Clinical Chemistry | Office | 47 | 36 | $3.41 | $160 |
| 93000 Electrocardiogram | Office | 45 | 42 | $8.63 | $389 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 32 | 32 | $17.25 | $552 |
| G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 20 | 20 | $156.83 | $3,137 |
By year: 2022 $184K for 2,954 services; 2023 $141K for 2,915 services; 2024 $144K for 4,912 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 194 | 117 | $9.47 | $1,837 |
| 81002 Clinical Chemistry | 47 | 36 | $3.41 | $160 |
Medicare prescription drug claims, 2024
In 2024, the drug Eugene D Gorski prescribed most often to Medicare patients was Atorvastatin Calcium, with 671 prescriptions and refills. In total Eugene D Gorski wrote 17,626 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 671 | 1,741 | 168 | $5,899 |
| Metoprolol Succinate Generic | 661 | 1,677 | 170 | $9,934 |
| Levothyroxine Sodium Generic | 627 | 1,562 | 145 | $5,715 |
| Valsartan Generic | 528 | 1,438 | 142 | $15K |
| Amlodipine Besylate Generic | 505 | 1,261 | 124 | $2,785 |
| Omeprazole Generic | 478 | 1,172 | 116 | $4,700 |
| Benazepril Hcl Generic | 397 | 1,055 | 95 | $3,771 |
| Tamsulosin Hcl Generic | 335 | 805 | 77 | $4,753 |
| Hydrochlorothiazide Generic | 331 | 873 | 89 | $1,592 |
| Losartan Potassium Generic | 318 | 857 | 84 | $3,183 |
| Prednisone Generic | 291 | 356 | 178 | $1,085 |
| Gabapentin Generic | 279 | 549 | 73 | $4,762 |
| Furosemide Generic | 268 | 631 | 81 | $1,119 |
| Eliquis Apixaban | 250 | 394 | 48 | $225K |
| Metformin Hcl Generic | 231 | 622 | 62 | $2,055 |
Brand drugs: 1,807 claims; generic drugs: 15,708 claims; opioid claims: 242.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Eugene D Gorski were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.